The 4 most recent market catalysts affecting $BMRA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 24, 2026
Corporate Catalyst
Neutral
Impact 55
Biomerica Files Prospectus Covering Resale Of Up To 1,403,705 Shares Of Common Stock By Selling Stockholders
Biomerica has filed an S-3 registration statement to allow certain selling stockholders to resell up to 1,403,705 shares of common stock. This is not a primary offering by Biomeric…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 92
Biomerica Q4 EPS $(0.38) Up From $(0.69) YoY, Sales $875.000K Up From $749.000K YoY
Biomerica's Q4 earnings report shows a notable improvement in its financial performance. The company reduced its losses per share by 44.93% year-over-year and increased sales by 16…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 65
Biomerica shares are trading higher after the company announced that it has entered into definitive agreements with institutional and individual investors for a private placement of 1,393,705 unregistered shares of the company’s common stock at a price of $1.60 per share.
This headline indicates a corporate action where Biomerica has successfully raised capital through a private placement. The immediate impact is positive for BMRA as it signals inve…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 55
Biomerica Commences ~$2.23M Private Placement Of 1.394M Shares At $1.60 Per Share
Biomerica has secured approximately $2.23 million through a private placement of 1.39 million shares at $1.60 per share. This capital infusion is positive for the company as it pro…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.